NRAS and melanoma: Among melanomas, 35–50% have mutation in the BRAF (v-Raf murine sarcoma viral oncogene homolog) gene, 10–25% at the neuroblastoma RAS viral oncogene homolog (NRAS), and 15% had loss of function mutation affecting neurofibromin 1 [36].